Skip to content

A randomized, rater-blinded, single-center study with cross-over waitlist design to assess the efficacy of an anti-freezing training against motor blocks in Parkinsons's disease

A randomized, rater-blinded, single-center study with cross-over waitlist design to assess the efficacy of an anti-freezing training against motor blocks in Parkinsons's disease

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00000070
Enrollment
50
Registered
2009-02-05
Start date
2009-02-04
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

G20

Interventions

Group 1: Arm 1: Two-week anti-freezing training with six training unit each lasting 30 min. Group 2: Arm 2: Same intervention (Two-week anti-freezing training with six training unit each lasting 30 mi

Sponsors

Neurologisches Krankenhaus München Zentrum für Parkinson und Bewegungsstörungen Schön Kliniken
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 80 Years

Inclusion criteria

Inclusion criteria: Anamnestic Freezing of Gait Diagnosis of idiopathic Parkinson's disease Hoehn & Yahr Stadium 1 hr Written informed consent

Exclusion criteria

Exclusion criteria: Parkinsonism of other etiology Clinically diagnosed dementia Severe internal disease, eg. cardiac insufficiency Severe orthopedic disease, eg. implant Deep brain stimulation

Design outcomes

Primary

MeasureTime frame
Freezing-of-Gait-Score at Visit 2, EARLY vs. LATE group

Countries

Germany

Contacts

Public ContactFrauke;Kerstin Schroeteler;Ziegler

Neurologisches Krankenhaus München Schön Kliniken;Neurologisches Krankenhaus München Schön Kliniken

FSchroeteler@Schoen-Kliniken.de;KZiegler@schoen-kliniken.de089-360870;089-360870

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026